A Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Forimtamig in Participants With Relapsed or Refractory Multiple Myeloma (r/r MM)
Clinical trial NCT04557150 · COMPLETED
Trial details
- NCT number
- NCT04557150
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-11
- Primary completion
- 2026-03-17
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.